- Investing Ideas
- Swedish Pharmaceuticals & Biotech Leverage Leaders
Swedish Pharmaceuticals & Biotech Leverage Leaders
Results
2
0 new
2 companies
Camurus
Market Cap: SEK 32.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 526.50
7D
-8.9%
1Y
-22.6%
BioArctic
Market Cap: SEK 27.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 314.00
7D
-2.7%
1Y
69.5%